Literature DB >> 33743038

Computed tomography in cystic fibrosis lung disease: a focus on radiation exposure.

Stella Joyce1, Brian W Carey1,2, Niamh Moore3, David Mullane1,4, Michael Moore2, Mark F McEntee3, Barry J Plant1,5,6, Michael M Maher1,2,6, Owen J O'Connor7,8,9.   

Abstract

Thoracic computed tomography (CT) is the imaging reference method in the diagnosis, assessment and management of lung disease. In the setting of cystic fibrosis (CF), CT demonstrates increased sensitivity compared with pulmonary function tests and chest radiography, and findings correlate with clinical outcomes. Better understanding of the aetiology of CF lung disease indicates that even asymptomatic infants with CF can have irreversible pulmonary pathology. Surveillance and early diagnosis of lung disease in CF are important to preserve lung parenchyma and to optimise long-term outcomes. CF is associated with increased cumulative radiation exposure due to the requirement for repeated imaging from a young age. Radiation dose optimisation, important for the safe use of CT in children with CF, is best achieved in a team environment where paediatric radiologists work closely with paediatric respiratory physicians, physicists and radiography technicians to achieve the best patient outcomes. Despite the radiation doses incurred, CT remains a vital imaging tool in children with CF. Radiologists with special interests in CT dose optimisation and respiratory disease are key to the appropriate use of CT in paediatric imaging. Paediatric radiologists strive to minimise radiation dose to children whilst providing the best possible assessment of lung disease.

Entities:  

Keywords:  Adolescents; Children; Computed tomography; Cystic fibrosis; Ionising radiation; Lung disease

Year:  2021        PMID: 33743038     DOI: 10.1007/s00247-020-04706-0

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  51 in total

1.  Cystic fibrosis drug Vertex's latest triumph.

Authors:  Heidi Ledford
Journal:  Nat Biotechnol       Date:  2012-03-07       Impact factor: 54.908

2.  Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis.

Authors:  P M Gustafsson; P A De Jong; H A W M Tiddens; A Lindblad
Journal:  Thorax       Date:  2007-08-03       Impact factor: 9.139

3.  Infection, inflammation, and lung function decline in infants with cystic fibrosis.

Authors:  Naveen Pillarisetti; Elizabeth Williamson; Barry Linnane; Billy Skoric; Colin F Robertson; Phil Robinson; John Massie; Graham L Hall; Peter Sly; Stephen Stick; Sarath Ranganathan
Journal:  Am J Respir Crit Care Med       Date:  2011-04-14       Impact factor: 21.405

4.  Progression of early structural lung disease in young children with cystic fibrosis assessed using CT.

Authors:  Lauren S Mott; Judy Park; Conor P Murray; Catherine L Gangell; Nicholas H de Klerk; Philip J Robinson; Colin F Robertson; Sarath C Ranganathan; Peter D Sly; Stephen M Stick
Journal:  Thorax       Date:  2011-12-26       Impact factor: 9.139

5.  Radiologic imaging in cystic fibrosis: cumulative effective dose and changing trends over 2 decades.

Authors:  Oisin J O'Connell; Sebastian McWilliams; AnneMarie McGarrigle; Owen J O'Connor; Fergus Shanahan; David Mullane; Joseph Eustace; Michael M Maher; Barry J Plant
Journal:  Chest       Date:  2011-12-29       Impact factor: 9.410

Review 6.  Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease.

Authors:  Dominique Debray; Deirdre Kelly; Roderick Houwen; Birgitta Strandvik; Carla Colombo
Journal:  J Cyst Fibros       Date:  2011-06       Impact factor: 5.482

7.  CORK Study in Cystic Fibrosis: Sustained Improvements in Ultra-Low-Dose Chest CT Scores After CFTR Modulation With Ivacaftor.

Authors:  Nicola J Ronan; Gisli G Einarsson; Maria Twomey; Denver Mooney; David Mullane; Muireann NiChroinin; Grace O'Callaghan; Fergus Shanahan; Desmond M Murphy; Owen J O'Connor; Cathy A Shortt; Michael M Tunney; Joseph A Eustace; Michael M Maher; J Stuart Elborn; Barry J Plant
Journal:  Chest       Date:  2017-10-14       Impact factor: 9.410

8.  A CFTR potentiator in patients with cystic fibrosis and the G551D mutation.

Authors:  Bonnie W Ramsey; Jane Davies; N Gerard McElvaney; Elizabeth Tullis; Scott C Bell; Pavel Dřevínek; Matthias Griese; Edward F McKone; Claire E Wainwright; Michael W Konstan; Richard Moss; Felix Ratjen; Isabelle Sermet-Gaudelus; Steven M Rowe; Qunming Dong; Sally Rodriguez; Karl Yen; Claudia Ordoñez; J Stuart Elborn
Journal:  N Engl J Med       Date:  2011-11-03       Impact factor: 91.245

9.  High-resolution computed tomography imaging of airway disease in infants with cystic fibrosis.

Authors:  Tanya M Martínez; Conrado J Llapur; Tamica H Williams; Cathy Coates; Richard Gunderman; Mervyn D Cohen; Michelle S Howenstine; Osama Saba; Harvey O Coxson; Robert S Tepper
Journal:  Am J Respir Crit Care Med       Date:  2005-07-28       Impact factor: 21.405

10.  Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis.

Authors:  P A de Jong; Y Nakano; M H Lequin; J R Mayo; R Woods; P D Paré; H A W M Tiddens
Journal:  Eur Respir J       Date:  2004-01       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.